Journey Medical Corp (DERM) — Strategic Asset Allocation Index
Journey Medical Corp (DERM) has a Strategic Asset Allocation Index of 2920.0% as of June 2023. Strategic assets (PP&E of $146.00K plus long-term investments of $-) total $146.00K, measured against net assets of $5.00K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Journey Medical Corp Strategic Asset Allocation Index (2019–2022)
This chart shows how Journey Medical Corp's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of June 2023, the index stands at 2920.0%, representing strategic assets of $146.00K against net assets of $5.00K USD. Explore cash efficiency ratio of Journey Medical Corp to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Journey Medical Corp (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Journey Medical Corp from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see DERM market cap.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 1.1% | $189.00K | $189.00K | $- | $16.98 Million | ▲ +0.9 pp |
| 2021 | 0.2% | $89.00K | $89.00K | $- | $42.04 Million | ▼ -1.5 pp |
| 2020 | 1.7% | $175.00K | $175.00K | $- | $10.29 Million | ▼ -1.5 pp |
| 2019 | 3.2% | $89.00K | $89.00K | $- | $2.75 Million | — |